Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Amplify Weight Loss Drug & Treatment ETF (THNR)

Amplify Weight Loss Drug & Treatment ETF (THNR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Amplify ETFs
  • Assets Under Management 4,739,800
  • Shares Outstanding, K 180
  • 60-Month Beta N/A
Trade THNR with:
  • Price/Earnings ttm N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Management Fee 0.59%
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.14 +1.26%
on 10/04/24
27.75 -4.61%
on 09/16/24
-0.58 (-2.15%)
since 09/09/24
3-Month
25.06 +5.63%
on 08/07/24
28.19 -6.11%
on 08/30/24
+0.22 (+0.83%)
since 07/09/24

Most Recent Stories

More News
Tap the Weight-Loss Drug Market With These ETFs

The weight-loss drug market is heating up with the introduction of GLP-1 pills. Novo Nordisk’s NVO Wegovy and Eli Lilly’s LLY Zepbound have been dominating this market and several other companies are...

RHHBY : 38.4100 (+0.37%)
NVO : 117.00 (-0.17%)
LLY : 919.74 (+0.66%)
HRTS : 33.10 (-0.30%)
THNR : 26.47 (+0.06%)
OZEM : 28.65 (-0.24%)

Fund Summary

The Amplify Weight Loss Drug and Treatment ETF seeks investment results that generally correspond to the performance (before fees and expenses) of the VettaFi Weight Loss Drug and Treatment Index.

See More

Top 10 Holdings

Name % Holdings
Novo Nordisk A/S ADR 13.22%
Astrazeneca Plc ADR 5.13%
Pfizer Inc 5.13%
N/A 5.11%
Thermo Fisher Scientific Inc 5.10%
Amgen Inc 5.07%
Merck & Company 4.98%
N/A 4.83%
N/A 4.80%
N/A 3.90%

See More

Key Turning Points

3rd Resistance Point 26.72
2nd Resistance Point 26.60
1st Resistance Point 26.54
Last Price 26.47
1st Support Level 26.36
2nd Support Level 26.24
3rd Support Level 26.18

See More

52-Week High 28.19
Fibonacci 61.8% 26.94
Fibonacci 50% 26.56
Last Price 26.47
Fibonacci 38.2% 26.17
52-Week Low 24.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar